MEDIFAST INC (MED): Price and Financial Metrics

MEDIFAST INC (MED): $49.99

1.47 (-2.86%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

A

Add MED to Watchlist
Sign Up

Industry: Medical - Consumer Goods

Industry

A

Ranked

#8 of 9

in industry

MED Price/Volume Stats

Current price $49.99 52-week high $115.32
Prev. close $51.46 52-week low $49.89
Day low $49.89 Volume 357,100
Day high $52.22 Avg. volume 296,082
50-day MA $61.27 Dividend yield N/A
200-day MA $76.88 Market Cap 544.54M

MED Stock Price Chart Interactive Chart >

MED POWR Grades

  • MED scores best on the Quality dimension, with a Quality rank ahead of 98.99% of US stocks.
  • The strongest trend for MED is in Quality, which has been heading down over the past 26 weeks.
  • MED's current lowest rank is in the Sentiment metric (where it is better than 5.01% of US stocks).

MED Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for MED is 6.31 -- better than 93.52% of US stocks.
  • With a price/earnings ratio of 6.25, MEDIFAST INC P/E ratio is greater than that of about only 7.81% of stocks in our set with positive earnings.
  • The ratio of debt to operating expenses for MEDIFAST INC is higher than it is for about just 7.57% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to MEDIFAST INC are BBW, RYI, IMKTA, GIC, and CAL.
  • MED's SEC filings can be seen here. And to visit MEDIFAST INC's official web site, go to medifastinc.com.

MED Valuation Summary

  • MED's price/sales ratio is 0.6; this is 70% lower than that of the median Consumer Cyclical stock.
  • Over the past 243 months, MED's price/sales ratio has gone down 5.2.

Below are key valuation metrics over time for MED.

Stock Date P/S P/B P/E EV/EBIT
MED 2023-12-29 0.6 3.8 6.1 4.3
MED 2023-12-28 0.6 3.8 6.2 4.3
MED 2023-12-27 0.6 3.8 6.1 4.2
MED 2023-12-26 0.6 3.8 6.1 4.3
MED 2023-12-22 0.6 3.8 6.1 4.2
MED 2023-12-21 0.6 3.8 6.2 4.3

MED Growth Metrics

    The year over year price growth rate now stands at -22.43%.
  • Its year over year cash and equivalents growth rate is now at -42.73%.
  • The year over year revenue growth rate now stands at 46.12%.
MED's revenue has moved up $1,325,766,000 over the prior 70 months.

The table below shows MED's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-12-31 1,598.577 194.57 143.568
2022-09-30 1,639.165 135.372 151.072
2022-06-30 1,662.162 95.776 156.899
2022-03-31 1,603.018 72.892 164.749
2021-12-31 1,526.087 94.545 164.031
2021-09-30 1,413.165 121.833 158.002

MED's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • MED has a Quality Grade of A, ranking ahead of 99.43% of graded US stocks.
  • MED's asset turnover comes in at 4.143 -- ranking 1st of 59 Food Products stocks.
  • TWNK, TOFB, and KHC are the stocks whose asset turnover ratios are most correlated with MED.

The table below shows MED's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 4.143 0.744 19.148
2021-03-31 4.006 0.739 72.885
2020-12-31 3.851 0.746 8.172
2020-09-30 3.779 0.746 4.378
2020-06-30 3.670 0.745 2.384
2020-03-31 3.596 0.753 1.821

MED Price Target

For more insight on analysts targets of MED, see our MED price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $363.33 Average Broker Recommendation 1.33 (Strong Buy)

MEDIFAST INC (MED) Company Bio


Medifast Inc. is a manufacturer and provider of clinically weight-loss and weight-maintenance products and programs. The company was founded in 1980 and is based in Owings Mills, Maryland.


MED Latest News Stream


Event/Time News Detail
Loading, please wait...

MED Latest Social Stream


Loading social stream, please wait...

View Full MED Social Stream

Latest MED News From Around the Web

Below are the latest news stories about MEDIFAST INC that investors may wish to consider to help them evaluate MED as an investment opportunity.

Medifast's (MED) Holistic Health Solution, Innovation Bode Well

Medifast's (MED) focus on combining lifestyle coaching with innovative health solutions and targeting diverse markets bode well amid challenges in customer acquisition and high costs.

Yahoo | December 26, 2023

Is Medifast, Inc. (NYSE:MED) Expensive For A Reason? A Look At Its Intrinsic Value

Key Insights Using the 2 Stage Free Cash Flow to Equity, Medifast fair value estimate is US$54.94 Medifast is estimated...

Yahoo | December 25, 2023

7 Dividend Stocks I Wouldn’t Touch With a 10-Foot Pole

Avoid these seven dividend stocks to sell at all costs, as their payouts may not be a sustainable as they seem.

Thomas Niel on InvestorPlace | December 18, 2023

Potential 300% Upside: Uncovering Medifast's Investment Opportunity

A look at the company's innovative wellness, robust growth and investment upside

Yahoo | December 15, 2023

Medifast (MED) Collaborates With LifeMD, Discontinues Dividend

Medifast (MED) penetrates the medically supported weight loss market via a collaboration with LifeMD, Inc. (LFMD). The company discontinues quarterly cash dividends.

Yahoo | December 14, 2023

Read More 'MED' Stories Here

MED Price Returns

1-mo -6.17%
3-mo -23.98%
6-mo -39.54%
1-year -54.13%
3-year -78.82%
5-year -53.63%
YTD -25.63%
2023 -38.34%
2022 -42.31%
2021 9.36%
2020 86.18%
2019 -9.73%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!